Literature DB >> 18035820

The role of fluorine in medicinal chemistry.

Poonam Shah1, Andrew D Westwell.   

Abstract

The small and highly electronegative fluorine atom can play a remarkable role in medicinal chemistry. Selective installation of fluorine into a therapeutic or diagnostic small molecule candidate can enhance a number of pharmacokinetic and physicochemical properties such as improved metabolic stability and enhanced membrane permeation. Increased binding affinity of fluorinated drug candidates to target protein has also been documented in a number of cases. A further emerging application of the fluorine atom is the use of 18F as a radiolabel tracer atom in the exquisitely sensitive technique of Positron Emission Tomography (PET) imaging. This short review aims to bring together these various aspects of the use of fluorine in medicinal chemistry applications, citing selected examples from across a variety of therapeutic and diagnostic settings. The increasingly routine incorporation of fluorine atom(s) into drug candidates suggests a bright future for fluorine in drug discovery and development. A major challenge moving forward will be how and where to install fluorine in a rational sense to best optimise molecular properties.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18035820     DOI: 10.1080/14756360701425014

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  82 in total

1.  Discovery of potent 2,4-difluoro-linker poly(ADP-ribose) polymerase 1 inhibitors with enhanced water solubility and in vivo anticancer efficacy.

Authors:  Wen-Hua Chen; Shan-Shan Song; Ming-Hui Qi; Xia-Juan Huan; Ying-Qing Wang; Hualiang Jiang; Jian Ding; Guo-Bin Ren; Ze-Hong Miao; Jian Li
Journal:  Acta Pharmacol Sin       Date:  2017-08-03       Impact factor: 6.150

2.  Optimization of propafenone analogues as antimalarial leads.

Authors:  David J Lowes; W Armand Guiguemde; Michele C Connelly; Fangyi Zhu; Martina S Sigal; Julie A Clark; Andrew S Lemoff; Joseph L Derisi; Emily B Wilson; R Kiplin Guy
Journal:  J Med Chem       Date:  2011-10-10       Impact factor: 7.446

3.  Design and Synthesis of Tetrazole- and Pyridine-Containing Itraconazole Analogs as Potent Angiogenesis Inhibitors.

Authors:  Yingjun Li; Kalyan Kumar Pasunooti; Hanjing Peng; Ruo-Jing Li; Wei Q Shi; Wukun Liu; Zhiqiang Cheng; Sarah A Head; Jun O Liu
Journal:  ACS Med Chem Lett       Date:  2020-04-08       Impact factor: 4.345

4.  Direct arene C-H fluorination with 18F- via organic photoredox catalysis.

Authors:  Wei Chen; Zeng Huang; Nicholas E S Tay; Benjamin Giglio; Mengzhe Wang; Hui Wang; Zhanhong Wu; David A Nicewicz; Zibo Li
Journal:  Science       Date:  2019-06-21       Impact factor: 47.728

5.  Identification of lead compounds for (99m)Tc and (18)F GPR91 radiotracers.

Authors:  Jeffrey Klenc; Malgorzata Lipowska; Andrew T Taylor
Journal:  Bioorg Med Chem Lett       Date:  2015-04-11       Impact factor: 2.823

6.  Deuteration and fluorination of 1,3-bis(2-phenylethyl)pyrimidine-2,4,6(1H,3H,5H)-trione to improve its pharmacokinetic properties.

Authors:  Guoyao Xia; Radhia Benmohamed; Richard I Morimoto; Donald R Kirsch; Richard B Silverman
Journal:  Bioorg Med Chem Lett       Date:  2014-09-15       Impact factor: 2.823

7.  Synthesis and Immunomodulatory Activity of Fluorine-Containing Bisphosphonates.

Authors:  Satoshi Mizuta; Mohammed S O Tagod; Masashi Iwasaki; Yoichi Nakamura; Hiroaki Senju; Hiroshi Mukae; Craig T Morita; Yoshimasa Tanaka
Journal:  ChemMedChem       Date:  2019-01-25       Impact factor: 3.466

8.  Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development.

Authors:  Jeffrey M Axten; Stuart P Romeril; Arthur Shu; Jeffrey Ralph; Jesús R Medina; Yanhong Feng; William Hoi Hong Li; Seth W Grant; Dirk A Heerding; Elisabeth Minthorn; Thomas Mencken; Nathan Gaul; Aaron Goetz; Thomas Stanley; Annie M Hassell; Robert T Gampe; Charity Atkins; Rakesh Kumar
Journal:  ACS Med Chem Lett       Date:  2013-08-12       Impact factor: 4.345

9.  Enantioselective Synthesis of Fluoro-Dihydroquinazolones and -Benzooxazinones by Fluorination-Initiated Asymmetric Cyclization Reactions.

Authors:  Kenichi Hiramatsu; Takashi Honjo; Vivek Rauniyar; F Dean Toste
Journal:  ACS Catal       Date:  2015-12-04       Impact factor: 13.084

10.  Optimizing small molecule inhibitors of calcium-dependent protein kinase 1 to prevent infection by Toxoplasma gondii.

Authors:  Sebastian Lourido; Chao Zhang; Michael S Lopez; Keliang Tang; Jennifer Barks; Qiuling Wang; Scott A Wildman; Kevan M Shokat; L David Sibley
Journal:  J Med Chem       Date:  2013-03-26       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.